Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alglucosidase Alfa in Chinese Infants with Pompe Disease
NCT03687333Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of alglucosidase alfa in Infantile-onset Pompe disease (IOPD), sponsored by Sanofi. Started Dec 2018; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Infantile-onset Pompe disease (IOPD)
Beyond the preview
Go deeper on NCT03687333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687333.